静脉血栓栓塞的风险和18种癌症之间的因果关系:双向的门德尔随机化分析
Naomi Cornish1,2, Philip Haycock3, Hermann Brenner4,5,6
1School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
International journal of epidemiology
|December 21, 2023
概括
静脉血栓栓塞 (VTE) 似乎不会导致癌症,尽管观察到的关联. 静脉瘤和癌症风险之间的联系可能是由于与活跃癌症及其治疗相关的其他因素.
科学领域:
- 遗传学 遗传学 是一个
- 流行病学 流行病学
- 在瘤学瘤学.
背景情况:
- 在癌症患者中,静脉血栓塞栓症 (VTE) 的发生率很高.
- 在第一次VTE事件后,观察到随后癌症的风险增加.
- 静脉瘤和癌症之间的因果关系尚不清楚.
研究的目的:
- 调查VTE的遗传责任与发展18种不同癌症的风险之间的因果关系.
- 为了确定VTE是否是癌症的因果风险因素,或者癌症是否会增加VTE风险.
主要方法:
- 利用了大量的全基因组关联研究元分析.
- 进行双向门德尔随机化分析.
- 检查了对VTE的遗传责任和18种癌症的风险.
主要成果:
- 没有发现确的证据表明VTE的遗传责任与癌症发病率之间存在因果关系,反之亦然.
- 观察到VTE责任和胰腺癌风险之间的关联,但可能是由血型变异驱动的.
- 敏感性分析表明没有强有力的因果关系.
结论:
- 结果不支持VTE遗传责任作为癌症的原因.
- 观察到的VTE与癌症之间的联系很可能是由癌症相关的病理生理学变化解释的.
- 需要进一步的研究来了解驱动静脉瘤与癌症关联的机制.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Hazard Ratio
129
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
129
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Statistical Methods for Analyzing Epidemiological Data
371
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
371
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Venous Return
4.4K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
4.4K


